echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The grass-roots market ushers in opportunities, and medical representatives do not have to worry too much!

    The grass-roots market ushers in opportunities, and medical representatives do not have to worry too much!

    • Last Update: 2019-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [trends of pharmaceutical network industry] with the continuous promotion of the policies of volume purchase and hierarchical diagnosis and treatment, the grass-roots market has become a new export for the performance growth of pharmaceutical enterprises In addition, the policy also benefits the primary market For example, the national health and Health Commission recently issued the notice on printing and distributing the list of pilot cities for the construction of urban medical consortia, which identified 118 pilot cities for the construction of urban medical consortia At the same time, the unified management mode of medical consortia is encouraged, the drug market structure is expected to be rebuilt, and the primary hospital market will also usher in more opportunities According to the industry, with the support of policies, the aging of the market, the increase of the number of patients with chronic diseases, the improvement of health management awareness of chronic patients such as hypertension and diabetes, the grass-roots market has broad prospects It is expected that in the future, drugs for chronic disease treatment will gain more development opportunities in county and grass-roots markets In addition, with the gradual establishment of close medical communities in 500 counties, it will be related to the transformation of the business model of pharmaceutical enterprises, and the procurement, payment, medication and management of pharmaceutical consumables will be greatly changed Therefore, pharmaceutical enterprises need to pay more attention to it In this context, domestic and foreign pharmaceutical companies have focused on grassroots market investment Among them, Bayer, Pfizer, Sanofi, Novo Nordisk, AstraZeneca and other foreign-funded pharmaceutical enterprises are targeting the urban grass-roots medical market; Kelun pharmaceutical, Wuzhou pharmaceutical, treasure island pharmaceutical, Chenxin pharmaceutical and other domestic funded pharmaceutical enterprises have long had a layout in the township grass-roots medical market, and accounted for a large proportion In addition, Pfizer, AstraZeneca, Bayer, MSD, GlaxoSmithKline and other foreign funded pharmaceutical companies are recruiting grassroots pharmaceutical representatives China Resources Shuanghe, Zhejiang Jingxin, Yunnan Baiyao and other domestic pharmaceutical enterprises are also actively layout In fact, a pharmaceutical personage disclosed earlier that major pharmaceutical companies are widely recruiting pharmaceutical representatives The main reason for expanding the recruitment scale is that some pharmaceutical companies are trying to sink and set up grassroots sales teams In addition, there are also some pharmaceutical companies that choose the cooperation mode and are ready to carry out further development in the grass-roots market For example, Pfizer is expanding a large number of pharmaceutical representatives in the primary market, which has opened up nearly 1000 positions; AstraZeneca has also started to recruit sales personnel in the primary market nationwide in 2019, covering 141 cities in 16 provinces
    Although looking at these pharmaceutical enterprises that recruit grassroots medical representatives, compared with foreign pharmaceutical enterprises, the salary given by domestic pharmaceutical enterprises is not very high, but the requirements basically include "those who have sales experience of foreign pharmaceutical enterprises and previous sales performance can be considered comprehensively and employed preferentially", in addition, they are also required to "have good local medical network contacts and be familiar with grassroots market sales model" Style It can be seen that the appeal of grass-roots market to pharmaceutical enterprises is increasing The survival crisis of medical representatives has been hanging over the industry for a long time The survey shows that a large number of medical representatives have been removed from their posts, of which 60 +% think that the change of internal strategy caused by policies and the difficulty of academic promotion are a big problem, and many medical representatives are considering transformation With the attraction of primary market, or provide new opportunities for medical representatives There has been an analysis of medical representatives Although the single output of cities like districts and counties is small, the number is huge A representative manages several districts and counties at a low cost, and wins by quantity, which will improve the income of medical representatives.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.